ev3, Inc.
9600 54th Avenue North
Suite 100
Plymouth,
MN 55442-2111
United States - Map
Phone: 763-398-7000
Fax: 763-398-7200
Web Site: http://www.ev3.net
| ev3 Inc. operates as an endovascular company that focuses on identifying and treating peripheral vascular disease, including lower extremity arterial disease and neurovascular disease. It develops, manufactures, and markets a range of products that include stents, atherectomy plaque excision products, thrombectomy and embolic protection devices, percutaneous transluminal angioplasty balloons, and other procedural support products for the peripheral vascular market. The company also offers embolic coils, liquid embolics, flow directed, and other micro catheters; occlusion balloon systems; guidewires; and neuro stents for the neurovascular market. It markets its products in the United States, Europe, and Canada through a direct sales force; and through distributors in other international markets. The companys customers include a section of physicians, including interventional radiologists, neuroradiologists, vascular surgeons, neuro surgeons, endovascular specialists, and interventional cardiologists. ev3 Inc. was founded in 2000 and is headquartered in Plymouth, Minnesota. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Robert J. Palmisano , 64
Chief Exec. Officer, Pres |
$
892.00K | N/A | Ms. Stacy Enxing Seng , 44
Exec. VP and Pres of Peripheral Vascular Division |
N/A
| N/A | Mr. Pascal E. R. Girin , 47
Exec. VP and Pres of Worldwide Neurovascular & International |
N/A
| N/A | Mr. Gregory Morrison , 46
Sr. VP of HR |
$
364.00K | N/A | Mr. Shawn McCormick , 45
Chief Financial Officer, Principal Accounting Officer and Sr. VP |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
Profile
